Popular topics to explore
Suven Life Sciences - Strong breakout
SUVEN has delivered a strong breakout from the ₹290–300 zone and has decisively moved into a higher trading range. The breakout above the previous swing resistance signals a clear improvement in momentum, with ₹300 now emerging as an impo…
Laurus Labs Delivers Record Quarter, Strengthening Pharma Sector Sentiment
The Pharmaceuticals sector remained in focus after Laurus Labs reported its highest-ever quarterly revenue, with Q1 revenue rising 29% year-on-year and net profit more than doubling to ₹368 crore. Adding to the positive sentiment, the compa…
Pharma Wars Go Legal: Why a US Weight-Loss Drug Battle Matters for Indian
InvestorsMarketing battles often reveal competitive pressure, creating opportunities for suppliers, manufacturers, and innovation leaders across the pharmaceutical ecosystem globally. Novo Nordisk has filed a lawsuit against Eli Lilly, all…
Suven Pharma: Stock Outlook
Suven Pharmaceuticals Ltd. is a leading pharmaceutical company specializing in contract development and manufacturing services (CDMO). It focuses on producing intermediates and active pharmaceutical ingredients (APIs), serving global pharma…
SUVEN
SUVEN leading CDMO (Contract Development and Manufacturing Organization) serving global pharmaceutical innovators. The company benefits from long-term customer relationships, strong capabilities in complex chemistry, and increasing outsour…
SUVEN
SUVEN LIFE SCIENCES: TO PRESENT 5 SCIENTIFIC POSTERS AT AAIC 2026 🧠🔬 • 🌍 Suven Life Sciences will present 5 scientific posters at the Alzheimer's Association International Conference (AAIC) 2026 in London from July 12–15. • 🧪 Key pre…
SUVEN Breakout
SUVEN Suven Life Sciences has broken above a long-standing resistance zone, confirming renewed buying interest.
I think a successful hold above the breakout level could set the stage for the next leg of the uptrend.
Showcase its Differentiated CNS Clinical Candidates - Suven Life Sciences Ltd
Code BSE: 530239 NSE: SUVEN
Suven Life Sciences to showcase its Differentiated CNS Clinical Candidates and Partnering Strategies at BIO International Convention 2026, 22-25, June 2026, San Diego, USA
Suven Life Sciences will welcome…
SUVEN Suven Life Sciences – High-Risk, High-Reward Innovation-Driven Pharma Bet
SUVEN Suven Life Sciences is a clinical-stage biopharmaceutical company focused on developing novel drugs for central nervous system (CNS) disorders, including Alzheimer's disease, sleep disorders, and depression. Unlike traditional pharma…
Topline results of First-in-Human (FIH) Phase-1 clinical study of SUVN-I6107 - Suven Life Sciences Ltd
Code BSE: 530239 NSE: SUVEN
Suven Life Sciences announces successful completion and topline results of First-in-Human (FIH) Phase-1 clinical study of SUVN-I6107, a Muscarinic M1 Positive Allosteric Modulator (M1-PAM) and its advancement…
Stock Under Pressure: Suven Life Sciences (SUVEN) Falls 9.46%
SUVEN Suven Life Sciences Ltd. witnessed sharp selling pressure today, with the stock declining 9.46% to ₹241.15.
The weakness comes amid concerns over the company's financial profile. While Suven has started generating operating revenue…
SUVEN
SUVEN LIFE SCIENCES : POSITIVE PHASE-3 UPDATE FOR ALZHEIMER'S DRUG 🧠💊 • ✅ Independent DSMB completed safety review and interim analysis of Masupirdine (SUVN-502) Phase-3 study • 👍 DSMB recommended the trial continue without any changes…
18th May · SEBI-Registered Analyst
Investment Insights with Adarsh · 18th May
Suven Life Sciences Fundamentals Overview
SUVEN
Suven Life Sciences operates in the pharmaceutical research and drug discovery segment with focus on central nervous system disorders and innovative therapies. Unlike traditional pharma companies that depend mainly on generic medici…
10th Apr · SEBI-Registered Analyst
Currency Grow (CA & SEBI Reg IA Omkar Bhutada) · 10th Apr
Suven Life Sciences – Rounding Bottom Breakout | 30% Upside Setup 🚀
SUVEN
This chart is showing a classic base formation breakout, supported by structure and momentum, indicating a strong positional opportunity.
Technical Structure (Elliott Wave + Price Action)
After a prolonged downtrend, the stock ha…
SUVEN - Multi year support
SUVEN has just officially tested its multi year support trendline drawn from lows of 2012. this is over 13 years of chart structure and stock is resting at 137, a sharp rebound from here can take SUVEN to 200 - 300 but a break from here…
📉 Cohance Lifesciences Hits Multi-Year Low — What’s Driving the Sharp Fall?
Shares of Cohance Lifesciences (NSE: COHANCE ), formerly known as Suven Lifesciences, have plunged to ₹311, marking a 52-week low and the lowest level since December 2020. The stock has corrected over 75% from its 52-week high of ₹1,328.
R…
Suven Life Sciences – Reversal Attempt from Oversold Zone
SUVEN 📊 Suven Life Sciences – Reversal Attempt from Oversold Zone
Timeframe: Daily
After a prolonged downtrend, the stock has shown a sharp bounce from the lower Bollinger Band with a strong bullish candle supported by volume expansion.…
SUVEN
Suven Life Sciences saw a healthy rally before pulling back about 50% from ₹300 to ₹160, finding support exactly at a key trendline. It's now bouncing from what appears to be a crucial accumulation zone. The stock has tested the ₹300 level…
The Most Impressive Earnings Performers in Small Caps! 📊 - Datamatics Global - R Systems International - Swaraj Engines - Kennametal India - VRL Logistics - Ashoka Buildcon - KNR Construction - Capillary Technologies - Electronics Mart -…
Contrasting Trends: Some Nifty 500 Stocks Slip to 52-Week Lows
While the Nifty 50 index trades close to its 52-week high, select stocks within the Nifty 500 are witnessing sharp corrections, trading near their yearly lows. DEEPAKNTR (₹1,718, ▼0.77%) has declined significantly from its high of ₹2,908…
